Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Citigroup Inc | 397.6K | -- | 2.65% | +396.8K | 2026-06-30 |
| CM Management, LLC | 300.0K | -- | 2.00% | +170.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 124.6K | -- | 0.83% | -- | 2026-06-30 |
| Pingora Partners LLC | 120.4K | -- | 0.80% | +84.6K | 2026-06-30 |
| UBS Group AG | 77.6K | -- | 0.52% | +73.2K | 2026-06-30 |
| Geode Capital Management, LLC | 66.7K | -- | 0.44% | -27.6K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 66.3K | -- | 0.44% | -- | 2026-06-30 |
| Brown Advisory Inc | 35.5K | -- | 0.24% | -- | 2026-06-30 |
| Commonwealth Equity Services, LLC | 23.4K | -- | 0.16% | -- | 2026-06-30 |
| Citadel Advisors LLC | 23.0K | -- | 0.15% | -40.4K | 2026-06-30 |
